Nicholas A Giorgio

Title: The Innovations of Nicholas A Giorgio

Introduction

Nicholas A Giorgio is a notable inventor based in Avenel, NJ (US). He has made significant contributions to the field of medical diagnostics, particularly in the determination of carcinoembryonic antigen (CEA). His innovative approach has the potential to enhance the accuracy of cancer detection.

Latest Patents

Nicholas A Giorgio holds a patent for a process titled "Carcinoembryonic antigen determination." This process involves contacting a slightly acidic buffered sample of serum or plasma with hydrophilic silica at room temperature. After separating the silica from the sample, a radioimmunoassay for carcinoembryonic antigen is carried out on the sample. This method represents a significant advancement in the field of medical diagnostics.

Career Highlights

Giorgio is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical and diagnostics industry. His work at this esteemed organization has allowed him to contribute to groundbreaking research and development in medical technology.

Collaborations

Throughout his career, Nicholas has collaborated with notable colleagues, including John Krupey and Leonard T Wilson. These partnerships have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Nicholas A Giorgio's contributions to the field of medical diagnostics through his innovative patent demonstrate his commitment to improving healthcare outcomes. His work continues to influence the industry and pave the way for future advancements.